Government approves scheme to strengthen drug regulatory system

Published On 2016-02-27 07:12 GMT   |   Update On 2016-02-27 07:12 GMT
Advertisement
NEW DELHI: The government has approved a scheme to strengthen the drug regulatory system for detecting distribution and marketing of spurious drugs in the country, Lok Sabha was informed.

Noting that Drugs and Cosmetics Act, 1940 has also been amended and provisions made for setting up of special courts, Union Health Minister J P Nadda said 26 states and Union Territories have also set up designated special courts for trial of offences under the Act.

"The government has approved a scheme for strengthening the drug regulatory system in the country both at the central as well as state level with an outlay of Rs 1,750 crore during 2015-16 to 2017-18," Nadda said in a written reply in Lok Sabha.

He said the scheme includes augmentation of human resources as well as physical infrastructure and e-governance to improve better coordination among the central and state regulatory authorities.

"Drugs and Cosmetics Act 1940 was amended in 2008 to provide stringent penalties for manufacture of spurious and adulterated drugs. Certain offences have also been made cognisable and non-bailable.

"Provisions have been made for setting up of special courts and 26 states and UTs have set up designated special courts for trial of offences under the Act," Nadda said.
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News